| 1 | Ursolic Acid Induces Beneficial Changes in Skeletal Muscle mRNA Expression and Increases Exercise Participation and Performance in Dogs with Age-Related Muscle Atrophy | 2.3 | 1 | Citations (PDF) |
| 2 | Defining and Addressing Research Priorities in Cancer Cachexia through Transdisciplinary Collaboration | 4.0 | 3 | Citations (PDF) |
| 3 | Blocking muscle wasting via deletion of the muscle-specific E3 ligase MuRF1 impedes pancreatic tumor growth | 4.5 | 15 | Citations (PDF) |
| 4 | GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscle | 5.5 | 4 | Citations (PDF) |
| 5 | Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery | 2.8 | 10 | Citations (PDF) |
| 6 | Depleting Ly6G Positive Myeloid Cells Reduces Pancreatic Cancer-Induced Skeletal Muscle Atrophy | 4.8 | 14 | Citations (PDF) |
| 7 | FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness | 9.1 | 23 | Citations (PDF) |
| 8 | The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer | 4.0 | 11 | Citations (PDF) |
| 9 | Phase II Study of 5-Fluorouracil, Oxaliplatin plus Dasatinib (FOLFOX-D) in First-Line Metastatic Pancreatic Adenocarcinoma | 3.6 | 9 | Citations (PDF) |
| 10 | MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer | 0.6 | 34 | Citations (PDF) |
| 11 | Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle | 9.1 | 31 | Citations (PDF) |
| 12 | Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia | 4.0 | 17 | Citations (PDF) |
| 13 | Pharmacological targeting of mitochondrial function and reactive oxygen species production prevents colon 26 cancer-induced cardiorespiratory muscle weakness | 1.7 | 21 | Citations (PDF) |
| 14 | Racial and ethnic disparities in a state‐wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities | 2.8 | 25 | Citations (PDF) |
| 15 | Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content | 1.5 | 24 | Citations (PDF) |
| 16 | An anti-CRF antibody suppresses the HPA axis and reverses stress-induced phenotypes | 8.1 | 10 | Citations (PDF) |
| 17 | IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy | 4.0 | 42 | Citations (PDF) |
| 18 | Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer | 0.6 | 37 | Citations (PDF) |
| 19 | Cancer cachexia impairs neural respiratory drive in hypoxia but not hypercapnia | 9.1 | 11 | Citations (PDF) |
| 20 | Interleukin‐8 is Released from Human Pancreatic Tumor and Stromal Cells, and Causative in Skeletal Muscle Atrophy | 0.7 | 0 | Citations (PDF) |
| 21 | Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival | 3.2 | 59 | Citations (PDF) |
| 22 | Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine | 4.5 | 14 | Citations (PDF) |
| 23 | Tumour‐derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour‐bearing mice | 9.1 | 74 | Citations (PDF) |
| 24 | Cold shock protein RBM3 attenuates atrophy and induces hypertrophy in skeletal muscle | 1.5 | 19 | Citations (PDF) |
| 25 | Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease | 1.0 | 33 | Citations (PDF) |
| 26 | A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer | 1.9 | 34 | Citations (PDF) |
| 27 | Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia | 1.7 | 27 | Citations (PDF) |
| 28 | Forelimb muscle plasticity following unilateral cervical spinal cord injury | 2.6 | 5 | Citations (PDF) |
| 29 | Janus kinase inhibition prevents cancer- and myocardial infarction-mediated diaphragm muscle weakness in mice | 2.5 | 8 | Citations (PDF) |
| 30 | Differential expression of <i>HDAC</i> and <i>HAT</i> genes in atrophying skeletal muscle | 2.6 | 15 | Citations (PDF) |
| 31 | NAD(P)H oxidase subunit p47<sup>phox</sup> is elevated, and p47<sup>phox</sup> knockout prevents diaphragm contractile dysfunction in heart failure | 3.3 | 32 | Citations (PDF) |
| 32 | Identification of the Acetylation and Ubiquitin-Modified Proteome during the Progression of Skeletal Muscle Atrophy | 2.5 | 41 | Citations (PDF) |
| 33 | HDAC1 activates FoxO and is both sufficient and required for skeletal muscle atrophy | 3.2 | 97 | Citations (PDF) |
| 34 | Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia | 3.0 | 84 | Citations (PDF) |
| 35 | Diaphragm and ventilatory dysfunction during cancer cachexia | 0.7 | 91 | Citations (PDF) |
| 36 | Loss of the Inducible Hsp70 Delays the Inflammatory Response to Skeletal Muscle Injury and Severely Impairs Muscle Regeneration | 2.5 | 100 | Citations (PDF) |
| 37 | Diaphragm Atrophy and Contractile Dysfunction in a Murine Model of Pulmonary Hypertension | 2.5 | 26 | Citations (PDF) |
| 38 | Temporal Changes in the Acetylation Profile of Skeletal Muscle Proteins during Atrophy | 0.7 | 0 | Citations (PDF) |
| 39 | Meeting Synopsis: Advances in Skeletal Muscle Biology in Health and Disease (Gainesville, Florida, February 22nd to 24th 2012) – Day 1: “Cell Signaling Mechanisms Mediating Muscle Atrophy and Hypertrophy” and “muscle Force, Calcium Handling, and Stress Response” | 3.0 | 3 | Citations (PDF) |
| 40 | Meeting Synopsis: Advances in Skeletal Muscle Biology in Health and Disease (Gainesville, Florida, February 22nd to 24th 2012) – Day 2: “Muscle Diseases and Regeneration” and “Clinical/Translational Research” | 3.0 | 0 | Citations (PDF) |
| 41 | Oxidative stress and disuse muscle atrophy | 3.2 | 195 | Citations (PDF) |
| 42 | Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy | 0.7 | 160 | Citations (PDF) |
| 43 | Putting the spice in weaning* | 0.6 | 0 | Citations (PDF) |
| 44 | Determination of Gene Promoter Activity in Skeletal Muscles In Vivo | 0.0 | 4 | Citations (PDF) |
| 45 | Long-term perturbation of muscle iron homeostasis following hindlimb suspension in old rats is associated with high levels of oxidative stress and impaired recovery from atrophy | 3.8 | 38 | Citations (PDF) |
| 46 | p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle | 4.4 | 86 | Citations (PDF) |
| 47 | FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70 | 4.4 | 154 | Citations (PDF) |
| 48 | Models of accelerated sarcopenia: Critical pieces for solving the puzzle of age-related muscle atrophy | 12.1 | 232 | Citations (PDF) |
| 49 | Foxo Signaling is Required for Muscle Atrophy Associated with Sepsis | 0.3 | 1 | Citations (PDF) |
| 50 | Hsp27 inhibits IKKβ‐induced NF‐κΕ activity and skeletal muscle atrophy | 0.7 | 70 | Citations (PDF) |
| 51 | Basic Science Review: The Myopathy of Peripheral Arterial Occlusive Disease: Part 2. Oxidative Stress, Neuropathy, and Shift in Muscle Fiber Type | 0.7 | 152 | Citations (PDF) |
| 52 | Hsp70 overexpression inhibits NF‐κB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy | 0.7 | 238 | Citations (PDF) |
| 53 | Hsp70 prevents disuse muscle atrophy in senescent rats | 3.6 | 27 | Citations (PDF) |
| 54 | Role for IκBα, but not c-Rel, in skeletal muscle atrophy | 4.4 | 91 | Citations (PDF) |
| 55 | Mitochondrial defects and oxidative damage in patients with peripheral arterial disease | 3.0 | 181 | Citations (PDF) |
| 56 | Life long calorie restriction increases heat shock proteins and proteasome activity in soleus muscles of Fisher 344 rats | 3.8 | 62 | Citations (PDF) |
| 57 | Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle | 1.8 | 53 | Citations (PDF) |
| 58 | MYOD1 functions as a clock amplifier as well as a critical co-factor for downstream circadian gene expression in muscle | 1.6 | 49 | Citations (PDF) |
